CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net income	$ 1,403	$ 818	$ 1,034
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	134	119	112
Deferred income taxes	(37)	(39)	(23)
Premium and discount amortization on available-for-sale securities and net gain/loss on other investments	15	57	14
Provisions/(benefits) for credit losses and legal and regulatory proceedings	(20)	257	59
Share-based compensation expense	132	120	112
Unrealized gain on company-owned life insurance policies, net of expenses	(150)	(46)	(10)
Losses on extinguishment of debt	98	0	0
Goodwill impairment	0	0	19
Other	66	92	51
Net change in:
Assets segregated for regulatory purposes excluding cash and cash equivalents	(2,100)	0	0
Collateralized agreements, net of collateralized financings	(29)	(55)	(101)
Loans provided to financial advisors, net of repayments	(90)	(49)	(79)
Brokerage client receivables and other receivables, net	(420)	127	682
Trading instruments, net	(141)	150	41
Derivative instruments, net	53	(51)	(144)
Other assets	16	(13)	(71)
Brokerage client payables and other payables	7,284	2,486	(1,231)
Accrued compensation, commissions and benefits	416	70	80
Purchases and originations of loans held for sale, net of proceeds from sales of securitizations and loans held for sale	(5)	11	32
Net cash provided by operating activities	6,625	4,054	577
Cash flows from investing activities:
Increase in bank loans, net	(4,027)	(1,136)	(1,605)
Proceeds from sales of loans held for investment	287	634	235
Purchases of available-for-sale securities	(4,218)	(5,710)	(1,027)
Available-for-sale securities maturations, repayments and redemptions	2,181	1,188	644
Proceeds from sales of available-for-sale securities	969	222	0
Business acquisitions, net of cash acquired	(266)	(5)	(5)
Additions to property and equipment	(74)	(124)	(138)
Other investing activities, net	8	(54)	(1)
Net cash used in investing activities	(5,140)	(4,985)	(1,897)
Cash flows from financing activities:
Increase in bank deposits	5,694	4,520	2,339
Purchases of treasury stock	(128)	(272)	(778)
Dividends on common stock	(218)	(205)	(191)
Exercise of stock options and employee stock purchases	53	62	65
Proceeds from senior notes issuances, net of debt issuance costs paid	737	494	0
Extinguishment of senior notes payable	(844)	0	0
Proceeds from Federal Home Loan Bank advances	0	850	850
Repayments of Federal Home Loan Bank advances and other borrowed funds	(31)	(855)	(855)
Proceeds from borrowings on the RJF Credit Facility	0	0	300
Repayment of borrowings on the RJF Credit Facility	0	0	(300)
Other financing, net	(9)	(1)	(57)
Net cash provided by financing activities	5,254	4,593	1,373
Currency adjustment:
Effect of exchange rate changes on cash	76	1	(23)
Net increase in cash and cash equivalents, including those segregated for regulatory purposes and restricted cash	6,815	3,663	30
Cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at beginning of year	9,634	5,971	5,941
Cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at end of year	16,449	9,634	5,971
Cash and cash equivalents	7,201	5,390	3,957
Cash and cash equivalents segregated for regulatory purposes and restricted cash	9,248	4,244	2,014
Supplemental disclosures of cash flow information:
Cash paid for interest	145	164	283
Cash paid for income taxes, net	437	246	$ 390
Cash outflows for lease liabilities	110	101
Non-cash right-of-use assets recorded for new and modified leases	$ 168	$ 74